Rapamycin-induced enhancement of vaccine efficacy in mice

Methods in Molecular Biology

Volumn 821, Issue , 2012, Pages 295-303

  Jagannath, Chinnaswamy ^a   Bakhru, Pearl ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

BCG vaccine; CD4; CD8 T cells; Mouse; mTOR; Mycobacterium tuberculosis; Rapamycin; Th1 immunity

Indexed keywords

BCG VACCINE; RAPAMYCIN; TARGET OF RAPAMYCIN KINASE;

ANIMAL; ARTICLE; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOLOGY; DENDRITIC CELL; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; IMMUNOLOGY; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MYCOBACTERIUM TUBERCULOSIS; PHAGOSOME; TH1 CELL; TUBERCULOSIS;

ANIMALS; BCG VACCINE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; HUMANS; MACROPHAGES; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; PHAGOSOMES; SIROLIMUS; TH1 CELLS; TOR SERINE-THREONINE KINASES; TUBERCULOSIS;

MUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 84555178660     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-430-8_18     Document Type: Article

References (13)

1. Luo, H., W. Duguid, H. Chen, M. Maheu, and J. Wu. 1994. The effect of rapamycin on T cell development in mice. Eur J Immunol 24:692-701. (Pubitemid 24076637)
2. Anderson, K. M., and J. C. Zimring. 2006. Rapamycin prolongs susceptibility of responding T cells to tolerance induction by CD8+ veto cells. Transplantation 81:88-94. (Pubitemid 43122154)
3. Araki, K., A. P. Turner, V. O. Shaffer, S. Gangappa, S. A. Keller, M. F. Bachmann, C. P. Larsen, and R. Ahmed. 2009. mTOR regulates memory CD8 T-cell differentiation. Nature 460:108-112.
4. Ferrer, I. R., M. E. Wagener, J. M. Robertson, A. P. Turner, K. Araki, R. Ahmed, A. D. Kirk, C. P. Larsen, and M. L. Ford. Cutting edge: Rapamycin augments pathogen-specific but not graft-reactive CD8+ T cell responses. J Immunol 185:2004-2008.
5. Saemann, M. D., M. Haidinger, M. Hecking, W. H. Horl, and T. Weichhart. 2009. The multifunctional role of mTOR in innate immunity: implications for transplant immunity. Am J Transplant 9:2655-2661.
6. Jagannath, C., D. R. Lindsey, S. Dhandayuthapani, Y. Xu, R. L. Hunter, Jr., and N. T. Eissa. 2009. Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nat Med 15:267-276.
7. Clemens, D. L., and M. A. Horwitz. 1996. The Mycobacterium tuberculosis phagosome interacts with early endosomes and is accessible to exogenously administered transferrin. J Exp Med 184:1349-1355. (Pubitemid 26354691)
8. Deretic, V., and R. A. Fratti. 1999. Mycobacterium tuberculosis phagosome. Mol Microbiol 31:1603-1609. (Pubitemid 29151262)
9. Russell, D. G. 2001. Mycobacterium tuberculosis: here today, and here tomorrow. Nat Rev Mol Cell Biol 2:569-577. (Pubitemid 33674008)
10. Singh, C. R., R. A. Moulton, L. Y. Armitige, A. Bidani, M. Snuggs, S. Dhandayuthapani, R. L. Hunter, and C. Jagannath. 2006. Processing and presentation of a mycobacterial antigen 85B epitope by murine macrophages is dependent on the phagosomal acquisition of vacuolar proton ATPase and in situ activation of cathepsin D. J Immunol 177:3250-3259. (Pubitemid 44277844)
11. Soualhine, H., A. E. Deghmane, J. Sun, K. Mak, A. Talal, Y. Av-Gay, and Z. Hmama. 2007. Mycobacterium bovis bacillus Calmette-Guerin secreting active cathepsin S stimulates expression of mature MHC class II molecules and antigen presentation in human macrophages. J Immunol 179:5137-5145.
12. Rao, R. R., Q. Li, K. Odunsi, and P. A. Shrikant. The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity 32:67-78.
13. Sathaliyawala, T., W. E. O'Gorman, M. Greter, M. Bogunovic, V. Konjufca, Z. E. Hou, G. P. Nolan, M. J. Miller, M. Merad, and B. Reizis. Mammalian target of rapamycin controls dendritic cell development downstream of Flt3 ligand signaling. Immunity 33:597-606.